AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Seeing and Measuring Hepatobiliary Disease Using Artificial Intelligence, Presented by Perspectum at RSNA 2019

November 14, 2019 GMT
Seeing and Measuring Hepatobiliary Disease Using Artificial Intelligence, Presented by Perspectum at RSNA 2019
Seeing and Measuring Hepatobiliary Disease Using Artificial Intelligence, Presented by Perspectum at RSNA 2019

OXFORD, England--(BUSINESS WIRE)--Nov 14, 2019--

Perspectum will be showcasing the application of Artificial Intelligence in their FDA-cleared, quantitative imaging services — Liver MultiScan for liver tissue characterization and MRCP+ for biliary tree visualization — at RSNA’s annual meeting this year.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191114005604/en/

Example MRCP+ Images (Graphic: Business Wire)

Perspectum’s co-founder, Professor Sir Michael Brady, will show how machine learning can be integrated with Liver MultiScan and MRCP+ to enhance disease detection with improved precision, and potentially monitor disease progression. A total of four abstracts highlighting the utility of Perspectum’s technology will be presented at RSNA.

Details of the presentations are listed below:

Oral presentations

  • A Machine Learning Pipeline for Automatic Multi-Site-Vendor Quantitative MRI Analysis of the Liver | SSE09-01 | Monday, 3:00 PM – 4:00 PM | Room N230B
  • Quantitative Biliary Tree Imaging by MRI: A Novel Method of Assessing Change Over Time in Hepatobiliary Disease via MRCP | SSG14-03 | Tuesday, 10:30 AM – 12:00 PM | Room S504AB
  • Diagnosis of Pediatric Liver Diseases with Multiparametric MRI and Quantitative Magnetic Resonance Cholangiopancreatography (MRCP) Analysis | RC413-02 | Tuesday, 3:00 PM – 6:00 PM | Room E353B

Poster presentation

  • Assessing the Accuracy, Reproducibility and Repeatability of Novel Quantitative Approach to MRCP Imaging | IN005-EB-SUB | Sunday 1:00 PM – 1:30 PM | Learning Center

Quantitative biliary tree imaging with MRCP+ reveals differences between AIH and PSC patients (images above). PSC patients show a significant increase in biliary tree strictures and dilatations between baseline and 1-year follow up, which is not observed in AIH patients.

“Monitoring progression of this unpredictable disease remains a major challenge for clinicians managing PSC patients. By objectively quantifying changes in the bile ducts, MRCP+ yields additional information to conventional MRCP. PSC Support is encouraged by this technology and we hope that it can help to reduce uncertainty for patients.” – Martine Walmsley, PSC Support

Visit Perspectum at booth #10112 in the AI showcase to find out more. To reserve a meeting or connect with the team, visit www.perspectum.com/contact

View source version on businesswire.com:https://www.businesswire.com/news/home/20191114005604/en/

CONTACT: Jasmin Hounsell 

Jasmin.Hounsell@perspectum.com

KEYWORD: EUROPE UNITED STATES UNITED KINGDOM NORTH AMERICA ILLINOIS

INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH MEDICAL DEVICES

SOURCE: Perspectum Diagnostics

Copyright Business Wire 2019.

PUB: 11/14/2019 11:17 AM/DISC: 11/14/2019 11:17 AM

http://www.businesswire.com/news/home/20191114005604/en